SB
CMPX icon

SIG Brokerage’s Compass Therapeutics CMPX Stock Holding History

SIG Brokerage’s Portfolio CMPX Stock Details CMPX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-40,000
Closed -$76K – 724
2025
Q1 		$76K Buy
+40,000
New +$106K ﹤0.01% 514

Other funds holding CMPX

TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $345M AUM 134.64% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

SIG Brokerage's CMPX Position: Q2 2026 in Review

SIG Brokerage held its Compass Therapeutics (CMPX) position steady in Q2 2026 at 14,496 shares worth $31.7K. The position accounts for ﹤0.01% of the portfolio, ranked #899.

SIG Brokerage first reported a position in CMPX in Q2 2025 and has held it in 5 quarters since. The position peaked at $94.6K in Q2 2025. 216 funds tracked by Wall St. Rank hold CMPX as of Q2 2026.

  • SIG Brokerage held 14,496 shares of Compass Therapeutics worth $31.7K as of Q2 2026.
  • SIG Brokerage left its Compass Therapeutics share count unchanged in Q2 2026.
  • Compass Therapeutics made up ﹤0.01% of SIG Brokerage's portfolio in Q2 2026, its #899 holding.
  • SIG Brokerage first reported a position in Compass Therapeutics in Q2 2025 and has held it in 5 quarters since.
  • SIG Brokerage's Compass Therapeutics position peaked at $94.6K in Q2 2025.
  • 216 funds tracked by Wall St. Rank held Compass Therapeutics as of Q2 2026.

Based on SIG Brokerage's 13F filing for Q2 2026, filed 14 Aug 2026.